Effects of chronic growth hormone and insulin‐like growth factor 1 deficiency on osteoarthritis severity in rat knee joints
Authors:
- Kari J. EkenstedtKEKari J. Ekenstedt
- William E. SonntagWSWilliam E. Sonntag
- Bruce R. LindgrenBLBruce R. Lindgren
- Cathy S. CarlsonCCCathy S. Carlson
Open Access
- 28 November 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (12) , 3850-3858
Abstract
Objective: To determine the effects of chronic deficiency of growth hormone (GH) and insulin‐like growth factor 1 (IGF‐1) on osteoarthritis (OA) severity.Methods: Thirty‐five rats were divided into 4 treatment groups at 4 weeks of age: 1 control group (normal GH/IGF‐1 levels [heterozygous]) and 3 groups of dwarves with a genetic mutation that results in GH deficiency. The first dwarf group received GH for 64 weeks (GH replete) and the second received GH until 14 weeks of age, followed by saline for 50 weeks (adult‐onset GH/IGF‐1 deficiency [AO‐GHD]). The third dwarf group received saline injections only (lifetime GH deficient [GHD]). Sections of the medial knee joint compartment were graded and measured histologically; data were summarized using factor analysis, and treatment effects were assessed using analysis of variance and adjusting for body weight.Results: Terminal IGF‐1 levels and body weights were significantly affected by treatment (P = 0.002 and P < 0.001, respectively). Factor analysis yielded a total of 5 factors, the first 3 of which were not significantly affected by treatment. Factor 4 (weighted by medial tibial plateau articular cartilage width and area) was significantly affected by treatment (P < 0.012), with larger values in the AO‐GHD group than in the GHD group (P < 0.05). Factor 5 (weighted primarily by articular cartilage structure and loss of toluidine blue staining scores) also was significantly affected by treatment (P < 0.001), and was significantly lower (less severe lesions) in the GH replete group than in all other treatment groups (P < 0.05). Despite the presence of cartilage lesions, osteophytes and subchondral sclerosis were not observed in GH/IGF‐1–deficient animals.Conclusion: These results indicate that chronic GH/IGF‐1 deficiency causes an increased severity of articular cartilage lesions of OA without the bony lesions normally seen in this disease.Keywords
This publication has 36 references indexed in Scilit:
- The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritisArthritis & Rheumatism, 2005
- Inhibitory Effects of Insulin-like Growth Factor-1 and Osteogenic Protein-1 on Fibronectin Fragment- and Interleukin-1β-stimulated Matrix Metalloproteinase-13 Expression in Human ChondrocytesJournal of Biological Chemistry, 2003
- Selective joint denervation promotes knee osteoarthritis in the aging ratJournal of Orthopaedic Research, 2002
- Aging and Immune Function: A Possible Role for Growth HormoneHormone Research, 1996
- Monoclonal antibodies that detect biochemical markers of arthritis in humansArthritis & Rheumatism, 1995
- Osteoarthritis in cynomolgus macaques II. Detection of modulated proteoglycan epitopes in cartilage and synovial fluidJournal of Orthopaedic Research, 1995
- Immunohistochemical analysis of 3‐b‐3(–) and 7‐d‐4 epitope expression in canine osteoarthritisArthritis & Rheumatism, 1993
- Generalized osteoarthritis associated with increased insulin‐like growth factor types i and ii and transforming growth factor β in cortical bone from the iliac crest. possible mechanism of increased bone density and protection against osteoporosisArthritis & Rheumatism, 1993
- Increased Population of Nonhormone-Proclucing Cells Suggests the Presence of Dysfunctional Growth Hormone Cells in the Anterior Pituitary Gland of the Spontaneous Dwarf RatNeuroendocrinology, 1993
- Effects of Body Weight Restriction on the Development and Progression of Spontaneous Osteoarthritis in Guinea PigsArthritis & Rheumatism, 1991